Browsing by Author "Landovitz, Raphael J."
Now showing items 1-13 of 13
-
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Tolley, Elizabeth E. et al. | Date Issued: 2020 -
Cabotegravir is not associated with weight gain in HIV-uninfected individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2019 -
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2020 -
Characterization of Human Immunodefciency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2021 -
Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots
Weld, Ethel D. et al. | Date Issued: 2023 -
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial
Hanscom, Brett S. et al. | Date Issued: 2022 -
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Marzinke, Mark A. et al. | Date Issued: 2023 -
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
Eshleman, Susan H. et al. | Date Issued: 2022 -
Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study
Seneviratne, Herana Kamal et al. | Date Issued: 2021 -
Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline
Coelho, Lara Esteves et al. | Date Issued: 2019 -
Promises and challenges: cabotegravir for preexposure prophylaxis
Spinelli, Matthew A. et al. | Date Issued: 2022 -
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
Landovitz, Raphael J. et al. | Date Issued: 2020